Endotoxin tolerance in monocytes can be mitigated by α2-interferon

Area of Science:

• Immunology
• Molecular Biology
• Epigenetics

Background:

• Endotoxin tolerance involves reduced inflammatory cytokine expression after repeated Toll-like receptor stimulation.
• Chromatin remodeling is a key mechanism regulating endotoxin tolerance.
• Type II interferon (IFN-γ) is known to reverse endotoxin tolerance.

Purpose of the Study:

• To investigate the effect of type I interferons on endotoxin tolerance.
• To determine if type I interferons can abrogate endotoxin tolerance.
• To explore the underlying molecular mechanisms, including chromatin modifications and transcription factor recruitment.

Main Methods:

• THP1 cells were used to model endotoxin tolerance.
• Messenger RNA (mRNA) levels of tolerance targets were measured.
• Chromatin immunoprecipitation was performed to assess histone modifications (H3K4me3, H3K4me2).
• Recruitment of Interferon Regulatory Factor 1 (IRF1) was analyzed.

Main Results:

• Type I interferon alpha-2 (α2-interferon) abrogated or diminished endotoxin tolerance.
• α2-interferon treatment increased H3K4me3 and H3K4me2 levels at tolerance target gene promoters during tolerization.
• These epigenetic marks were normalized following α2-interferon exposure.
• IRF1 recruitment correlated with both the establishment and inhibition of tolerance.

Conclusions:

• Type I interferons, specifically α2-interferon, can effectively inhibit endotoxin tolerance.
• α2-interferon acts, in part, by modifying chromatin at tolerance target genes.
• This suggests at least two distinct pathways exist for mitigating endotoxin tolerance, involving both type I and type II interferons.